Apnimed Completes Oversubscribed $79.75 Million Series C Extension Financing To Fund Two Planned Phase 3 Trials Of Ad109, An Oral Medication With The Potential To Be The First Therapy For Direct Treatment Of Obstructive Sleep Apnea (Osa)
Amount Raised
$79.8 Million
Round Type
Series C
CambridgeManufacturingHealthcareDescription
Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders, announced today that it has secured $79.75 million in an oversubscribed financing round that extends its Series C financing to a total of $142.25 million. The financing was led by existing investor Alpha Wave Ventures and included existing investors Sectoral Asset Management, Columbia-Seligman Investments and Tao Capital Partners, among others.
Quick answer
Apnimed raised $79.8 Million in a Series C round, dated January 3, 2023. Apnimed is based in Cambridge, Massachusetts, United States.
- How much did Apnimed raise?
- Apnimed raised $79.8 Million in a Series C round on January 3, 2023.
- What does Apnimed do?
- Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective..
- Where is Apnimed based and how big is it?
- Apnimed is based in Cambridge, Massachusetts, United States. Fundz records about 82 employees.
- Who are the decision-makers at Apnimed?
- Fundz holds 1 contact at Apnimed. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Manufacturing around the same time
Companies in the same sectors as Apnimed that raised within 45 days of this round, from Fundz verified event records.
- Zyus raised $19K (Pre-Seed) on February 16, 2023.
- Arthrosi Therapeutics raised $15M on February 7, 2023.
- Ensysce Biosciences raised $2.8M (Seed) on February 2, 2023.
- OnPoint Surgical raised $16 (Pre-Seed) on January 23, 2023.
- Neptune Wellness Solutions raised an undisclosed amount (Debt Financing) on January 13, 2023.
- ByHeart raised $30M on December 30, 2022.
Who to call at Apnimed, and when
A new round usually means Apnimed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Apnimed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Apnimed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Apnimed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Apnimed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Apnimed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.